IL97211A0 - Pharmaceutical composition comprising bisoprolol - Google Patents

Pharmaceutical composition comprising bisoprolol

Info

Publication number
IL97211A0
IL97211A0 IL97211A IL9721191A IL97211A0 IL 97211 A0 IL97211 A0 IL 97211A0 IL 97211 A IL97211 A IL 97211A IL 9721191 A IL9721191 A IL 9721191A IL 97211 A0 IL97211 A0 IL 97211A0
Authority
IL
Israel
Prior art keywords
bisoprolol
pharmaceutical composition
acceptable salts
relates
physiologically acceptable
Prior art date
Application number
IL97211A
Other versions
IL97211A (en
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL97211A0 publication Critical patent/IL97211A0/en
Publication of IL97211A publication Critical patent/IL97211A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Abstract

The invention relates to a pharmaceutical preparation containing bisoprolol and/or one of its physiologically acceptable salts and a potassium channel activator.
IL9721191A 1990-02-13 1991-02-11 Pharmaceutical composition comprising bisoprolol and a patassium channel activator IL97211A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4004268A DE4004268A1 (en) 1990-02-13 1990-02-13 PHARMACEUTICAL PREPARATION

Publications (2)

Publication Number Publication Date
IL97211A0 true IL97211A0 (en) 1992-08-18
IL97211A IL97211A (en) 1995-07-31

Family

ID=6399970

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9721191A IL97211A (en) 1990-02-13 1991-02-11 Pharmaceutical composition comprising bisoprolol and a patassium channel activator

Country Status (16)

Country Link
EP (1) EP0442141B1 (en)
JP (1) JPH04234813A (en)
KR (1) KR910015294A (en)
AT (1) ATE102031T1 (en)
AU (1) AU642961B2 (en)
CA (1) CA2036091A1 (en)
DE (2) DE4004268A1 (en)
DK (1) DK0442141T3 (en)
ES (1) ES2062287T3 (en)
HU (1) HU208483B (en)
IE (1) IE64207B1 (en)
IL (1) IL97211A (en)
NO (1) NO910566L (en)
NZ (1) NZ237092A (en)
PT (1) PT96719A (en)
ZA (1) ZA911074B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209071A1 (en) * 1992-03-20 1993-09-23 Merck Patent Gmbh PHARMACEUTICAL PREPARATION
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
IE910473A1 (en) 1991-08-14
AU642961B2 (en) 1993-11-04
EP0442141A1 (en) 1991-08-21
NZ237092A (en) 1993-01-27
HU208483B (en) 1993-11-29
NO910566L (en) 1991-08-14
PT96719A (en) 1991-10-31
KR910015294A (en) 1991-09-30
IL97211A (en) 1995-07-31
NO910566D0 (en) 1991-02-12
ZA911074B (en) 1991-11-27
DE59004798D1 (en) 1994-04-07
ATE102031T1 (en) 1994-03-15
AU7102991A (en) 1991-08-15
EP0442141B1 (en) 1994-03-02
DE4004268A1 (en) 1991-08-14
ES2062287T3 (en) 1994-12-16
DK0442141T3 (en) 1994-03-28
HUT59593A (en) 1992-06-29
HU910463D0 (en) 1991-08-28
IE64207B1 (en) 1995-07-12
CA2036091A1 (en) 1991-08-14
JPH04234813A (en) 1992-08-24

Similar Documents

Publication Publication Date Title
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
GR3006177T3 (en)
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
NZ216306A (en) Pharmaceutical compositions containing tissue plasminogen activator
NZ216307A (en) Pharmaceutical compositions containing tissue plasminogen activator
IL98756A0 (en) Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation
IL92358A0 (en) Diaryl compounds,their preparation and pharmaceutical compositions containing them
SE8404065D0 (en) NOVEL BIOLOGICALLY ACTIVE COMPOUNDS
EP0407192A3 (en) 4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing same
NZ222879A (en) Pharmaceutical composition containing ranitidine
IL81410A (en) Pharmaceutical compositions containing substituted n-arylmethylamine derivatives,certain such novel compounds and their preparation
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
IL97211A0 (en) Pharmaceutical composition comprising bisoprolol
DK374988A (en) TERTIARY 2,5-DIALKYL-3-PHENYLPIPERIDINE DERIVATIVES WITH OPIAT ANTAGONISTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS
GR1002576B (en) Pharmaceutical compositions and a process for the preparation thereof.
TW218011B (en)
IL99233A0 (en) Phosphonopyrrolidine-and phosphonopiperidine-containing pseudopeptides of the statin type,their preparation and pharmaceutical compositions containing them
IL106289A0 (en) Phospholipid derivatives, their preparation and pharmaceutical compositions containing them
ES2064652T3 (en) DERIVATIVES OF NAFTALENO- AND TETRAHIDRONAFTALENO-GEM-DIFOSFONATO.
IL91864A0 (en) Pharmaceutical compositions containing 4-bitrophenyl-dihydropyridine amides,certain such novel compounds and their preparation
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
TW228524B (en)
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
AU6961191A (en) Synthesis, composition and medical application of cyclic pentaborate compounds

Legal Events

Date Code Title Description
CB Opposition filed against grant of patent

Free format text: 31.10.95